Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
REPLAY HPE Female is a gender-specific biological extract derived from human placenta tissue (specifically from female births), developed by RegenMed Asia. It is a placental protein concentrate processed to preserve the integrity of bioactive components, including growth factors, peptides, amino acids, vitamins, trace elements, and hormones. The product is designed to address women's health concerns such as menopause symptoms, fertility, and libido, while also promoting anti-aging, skin rejuvenation, metabolic health, and immune function. Its mechanism involves the delivery of complex bioactive molecules that support cellular renewal, tissue regeneration, and immune/metabolic modulation. It is administered as a sterile preparation and is marketed as the first gender-specific placenta-based product line, recognizing epigenetic and hormonal variations between male and female placentas.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on REPLAY HPE Female.